FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

3725411000001102: Neostigmine 15mg tablets (Cambridge Laboratories) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17663901000001117 Neostigmine 15mg tablets (Cambridge Laboratories) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
61511901000001115 Neostigmine 15mg tablets (Alliance Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neostigmine 15mg tablets (Cambridge Laboratories) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Neostigmine 15mg tablets (Cambridge Laboratories) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Neostigmine 15mg tablets (Cambridge Laboratories) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Neostigmine 15mg tablets (Cambridge Laboratories) Has excipient Lactose false Inferred relationship Existential restriction modifier
Neostigmine 15mg tablets (Cambridge Laboratories) Is a Product containing precisely neostigmine bromide 15 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Neostigmine 15mg tablets (Cambridge Laboratories) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Neostigmine 15mg tablets (Cambridge Laboratories) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Neostigmine 15mg tablets (Cambridge Laboratories) Has active ingredient Neostigmine bromide false Inferred relationship Existential restriction modifier
Neostigmine 15mg tablets (Cambridge Laboratories) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Neostigmine 15mg tablets (Cambridge Laboratories) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Neostigmine 15mg tablets (Cambridge Laboratories) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Neostigmine 15mg tablets (Cambridge Laboratories) Has specific active ingredient Neostigmine bromide true Inferred relationship Existential restriction modifier
Neostigmine 15mg tablets (Cambridge Laboratories) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Neostigmine 15mg tablets (Cambridge Laboratories) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Neostigmine 15mg tablets (Cambridge Laboratories) 140 tablet Is pack of False Neostigmine 15mg tablets (Cambridge Laboratories) Inferred relationship Existential restriction modifier
Neostigmine 15mg tablets (Cambridge Laboratories) 140 tablet Has AMP True Neostigmine 15mg tablets (Cambridge Laboratories) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start